Table 3. Coagulation Profile According to Pre-Injury Antithrombotic Status.
AT (−) | Aspirin | Clopidogrel | Warfarin | Rivaroxaban | |
Number | 72 | 89 | 18 | 46 | 4 |
International Normalized Ratio | 1.2±0.2 | 1.4±0.8 | 1.3±0.7 | 2.8±0.9** | 1.5±0.6 |
Partial Thromboplastin Time | 29±5 | 31±7 | 28±7 | 38±8** | 29±6 |
Platelet Count | 211±64 | 215±75 | 215±64 | 199±60 | 215±71 |
R-Time | 4.1±1.3 | 5.5±2.1 | 4.8±1.3 | 6.4±2.2** | 3.8±1.8 |
K-Time | 1.2±0.4 | 1.4±0.6 | 1.3±0.3 | 1.5±0.5 | 1.1±0.4 |
Alpha Angle | 72±5 | 69±9 | 71±4 | 69±7 | 64±22 |
Maximum Amplitude | 65±6 | 67±5 | 66±5 | 67±4 | 65±9 |
Coagulation Index | 2.6±1.6 | 1.5±2.4** | 2.2±1.3 | 1.0±2.2** | 2.1±3.4 |
Arachidonic Acid % inhibition | 41±42 | 62±31** | 52±37 | 35±39 | 29±50 |
Adenosine Diphosphate % inhibition | 44±23 | 48±33 | 49±30 | 40±26 | 50±27 |
AT (−), Antithrombotic-negative;
**: P<0.05, compared to Antithrombotic-negative group